Región Metropolitana de Santiago
Este organismo compró $13.486.726.006.527 en 34.361 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $951,1 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 621-331-SE26 | 21-04-2026 | Farmaceutica Caribean SpA | Aceptada | $1.159.563.346 |
| 621-351-SE26 | 21-04-2026 | Laboratorio Sanderson S.A. | Aceptada | $90.960.863 |
| 621-423-SE26 | 21-04-2026 | Industrial y Comercial Baxter de Chile Limitada | Aceptada | $239.134.137 |
| 621-227-TD26 | 21-04-2026 | Advance Scientific de Chile SpA | Aceptada | $194.136.600 |
| 621-442-SE26 | 21-04-2026 | Consultora y Asesorias Oscar Berdichevsky EIRL | Aceptada | $37.894.360 |
| 621-445-TD26 | 21-04-2026 | Pfizer Chile S.A. | Aceptada | $18.195.745.575 |
| 621-279-SE26 | 21-04-2026 | Laboratorio Sanderson S.A. | Aceptada | $2.231.551.022 |
| 621-381-SE26 | 21-04-2026 | Lorenzo Jimenez e Hijo Ltda. | Aceptada | $245.288.512 |
| 621-384-SE26 | 21-04-2026 | Ic Global Chile SpA | Aceptada | $146.401.416 |
| 621-443-SE26 | 21-04-2026 | Inversiones C & F SpA | Aceptada | $138.109.020 |
| 621-450-SE26 | 21-04-2026 | Bestpharma S.A. | Aceptada | $522.212.222 |
| 621-296-SE26 | 20-04-2026 | Centro Especialidades Farmaceuticas Limitada | Aceptada | $525.667.744 |
| 621-297-SE26 | 20-04-2026 | Synthon Chile Limitada | Aceptada | $419.296.500 |
| 621-307-SE26 | 20-04-2026 | Farmaceutica Santiago dos SpA | Aceptada | $508.224.529 |
| 621-271-SE26 | 20-04-2026 | Merck S.A. | Aceptada | $421.260.000 |
| 621-317-SE26 | 20-04-2026 | Inversiones Sb S.A. | Aceptada | $34.181.608 |
| 621-340-SE26 | 20-04-2026 | Ascend Laboratories SpA | Aceptada | $627.794.496 |
| 621-392-SE26 | 20-04-2026 | Celltrion Healthcare Chile SpA | Aceptada | $260.963.573 |
| 621-400-SE26 | 20-04-2026 | Importadora Rm S.A. | Aceptada | $88.005.843 |
| 621-168-SE26 | 20-04-2026 | Laboratorio Chile S.A. | Aceptada | $846.401.304 |
| 621-285-SE26 | 20-04-2026 | Laboratorio Fleming SpA | Aceptada | $625.394.385 |
| 621-352-SE26 | 20-04-2026 | Ic Global Chile SpA | Aceptada | $114.085.062 |
| 2268-75-AG26 | 20-04-2026 | Administradora de Servicios Integrales Asi Retail Limitada | Aceptada | $761.600 |
| 621-439-SE26 | 20-04-2026 | Inversiones Sb S.A. | Aceptada | $40.983.600 |
| 621-436-TD26 | 17-04-2026 | Mayordent Dental Limitada | Aceptada | $109.663.706 |
| 2268-72-SE26 | 17-04-2026 | Procesos Sanitarios SpA | Aceptada | $29.232.532 |
| 2268-63-SE26 | 17-04-2026 | Cloudlatam SpA | Aceptada | $128.948.400 |
| 2268-71-SE26 | 17-04-2026 | Indra Solutions SpA | Aceptada | $13.744.500 |
| 621-224-SE26 | 16-04-2026 | Neoethicals Chile SpA | Aceptada | $1.228.313.985 |
| 621-262-SE26 | 16-04-2026 | Aventis Pharma Holding Gmbh | Aceptada | $3.470.861.100 |
